Food News and Research

RSS

Government, development sector leaders should turn to Bangladesh program for solutions to avoidable childhood death

For solutions to help end avoidable child deaths, "government and development sector leaders should heed the lessons of a massive-yet-innovative program" in Bangladesh, called SHOUHARDO, a Bangla word for "friendship," "that is not only helping children ... reach their fifth birthdays but also ensuring they grow healthier, and in many cases, taller," Faheem Khan of CARE Bangladesh, who heads the SHOUHARDO program, writes in this Christian Science Monitor opinion piece.

11 May 2012

FDA ADAC recommends approval of Gilead’s Truvada for HIV

Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to support approval of once-daily oral Truvada(emtricitabine and tenofovir disoproxil fumarate) to reduce the risk of HIV-1 infection among uninfected adults, an HIV prevention strategy called pre-exposure prophylaxis or PrEP.

11 May 2012

ChromaDex reports total revenues of $1.8 million for first quarter 2012

ChromaDex Corporation an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced its financial results for the first quarter of 2012.

11 May 2012

New University of Florida research center to focus on rare genetic illness

With the support of a Major League Baseball star, a new University of Florida research center on an island settled by the Vikings could lead to breakthroughs about a rare genetic disorder and potentially change the course of care for high blood pressure and other common conditions.

10 May 2012

Senate embroiled in partisan struggle over student loan rates

At issue is how to pay for an extension of the current interest rate. Democrats propose increasing the Social Security and Medicare payroll taxes on high-earning stockholders of some privately owned corporations. Republicans would like to take funds from the health law's prevention fund.

10 May 2012

McDonald’s introduces “healthy” fruit drink for kids – but experts say it contains too much sugar

McDonald’s is all set to introduce a ‘healthy’ fizzy drink for children that promises one of their five-a-day portions of fruit and vegetables. However the drink is packed with sugar and calories.

10 May 2012

Fast track approval process for “breakthrough” drugs proposed in the U.S.

Some experimental drugs that show a big effect early in development for treating serious or life-threatening diseases could soon get a faster and cheaper path to U.S. approval, under a proposal likely to become law this year.

10 May 2012

Obesity report proposes sweeping changes in schools, communities, workplaces

The Institute of Medicine panel recommended five critical areas to focus on to lower obesity: physical activity, food and beverage, marketing, work and schools.

10 May 2012

BBI from soybeans shows promise against cancer

Soybeans soaking in warm water could become a new "green" source for production of a cancer-fighting substance now manufactured in a complicated and time-consuming industrial process, scientists are reporting in ACS' Journal of Agricultural and Food Chemistry.

10 May 2012

Novel tiny spectrometer can detect food quality

Whether fruit, meat or cheese - the quality of food is not always as consumers would like it to be. But, in future, a spectrometer will allow them to gage the quality of food before they buy it. No bigger than a sugar cube, the device is inexpensive to manufacture and could one day even be installed in smartphones.

10 May 2012

Sunovion announces results from LATUDA open-label study for schizophrenia

Sunovion Pharmaceuticals Inc. today announced results from an open-label study that switched clinically stable, but symptomatic adult outpatients with schizophrenia from other antipsychotic agents to LATUDA.

10 May 2012

LifeBridge Health wins three prestigious Partner for Change Awards

LifeBridge Health has been honored for a second straight year with three prestigious Partner for Change Awards for its commitment to protecting the environment and human health by Practice Greenhealth, a national membership organization for health care facilities dedicated to environmentally responsible operations. The awards are given each year for outstanding environmental achievements in the health care sector.

10 May 2012

With teamwork and partnerships, successes experienced in Millennium Villages can be extended globally

In this post in the Huffington Post's "Global Motherhood" blog, Jeffrey Sachs, director of the Earth Institute at Columbia University, Sonia Sachs, director of health at the Millennium Villages Project (MVP), and Prabhjot Singh, assistant professor of international and public affairs at the MVP, respond to a study on the MVP, published in the Lancet on Tuesday, writing, "These results ... reinforce the global effort to build effective, low-cost, community-led health care systems that can end millions of deaths of young children and pregnant women each year."

10 May 2012

EU and U.S. regulatory authorities accept Biogen Idec’s BG-12 NDA for review

Today Biogen Idec announced that U.S. and EU regulatory authorities have accepted the company's marketing applications for the review of BG-12 (dimethyl fumarate), an oral therapeutic candidate for the treatment of multiple sclerosis.

10 May 2012

$Women with spine fractures can benefit from alendronate therapy$

Women with spine fractures can benefit from alendronate therapy

Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate - a class of drugs that prevent loss of bone mass.

10 May 2012

Discovery Labs reports data from SURFAXIN preclinical study on RDS

Discovery Laboratories, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, reported that data from a preclinical study of SURFAXIN LS (lyophilized KL4 surfactant) was recently published in the May issue of Pediatric Research.

10 May 2012

Scientists pinpoint mechanism essential for memory formation

Now, in a study that appears in the May 10, 2012 issue of the journal Neuron, scientists from the Florida campus of The Scripps Research Institute have pinpointed a mechanism that is essential for forming memories in the first place and, as it turns out, is equally essential for eliminating them after memories have formed.

10 May 2012

IDRI, Aeras partner to develop new TB vaccine candidate

Aeras and the Infectious Disease Research Institute (IDRI) announce today a new agreement to conduct joint development activities with respect to IDRI's novel tuberculosis vaccine candidate. This collaboration reflects the missions of the two non-profit product development partnerships to use cutting-edge science to develop products that address critical diseases of underserved populations around the world, including tuberculosis.

10 May 2012

FDA AAC recommends approval of Pfizer’s tofacitinib for RA

Pfizer Inc. announced today that the Arthritis Advisory Committee to the U.S. Food and Drug Administration (FDA) voted 8-2 to recommend approval of the investigational agent tofacitinib for the treatment of adult patients with moderately to severely active rheumatoid arthritis.

10 May 2012

Janssen submits XARELTO sNDA with FDA to reduce risk of stent thrombosis in ACS patients

Janssen Research & Development, LLC announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO, an oral anticoagulant, to reduce the risk of stent thrombosis in patients with Acute Coronary Syndrome.

10 May 2012